PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
Dallas, TX
CIK
0001047859
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 15 43,599 NVGS, AEM, EPSN, UBSG.SW 13F-HR 2/14/2024 000104785924000001
Q3 2023 10 30,517 NVGS, AEM, EPSN, IRIX 13F-HR 11/14/2023 000104785923000005
Q2 2023 13 48,870 NVGS, AEM, URI, CF 13F-HR 8/14/2023 000104785923000004
Q1 2023 11 48,057 NVGS, AEM, URI, EPSN 13F-HR 5/15/2023 000104785923000003
Q4 2022 17 53,680 NVGS, EPSN, APA, URI 13F-HR 2/13/2023 000104785923000002
Q3 2022 12 49,537 APA, NVGS, EPSN, SPY 13F-HR 11/14/2022 000104785922000004
Q2 2022 11 51,206 NVGS, AR, AEM, EPSN 13F-HR 8/16/2022 000104785922000003
Q1 2022 7 53,676 NVGS, AEM, APA, AR 13F-HR 5/16/2022 000104785922000002
Q4 2021 10 62,519 SPY, NVGS, AEM, EPSN 13F-HR 2/14/2022 000104785922000001
Q3 2021 17 88,448 SPY, NVGS, EPSN, VRS 13F-HR 11/15/2021 000104785921000004
Q2 2021 16 75,163 NVGS, RETA, MLKN, IRIX 13F-HR 8/16/2021 000104785921000003
Q1 2021 11 65,607 NEM, NVGS, RETA, IRIX 13F-HR 5/14/2021 000104785921000002
Q4 2020 10 65,028 RETA, NEM, NVGS, EPSN 13F-HR 2/12/2021 000104785921000001
Q3 2020 8 74,494 SPY, NEM, RETA, NVGS 13F-HR 11/13/2020 000160501820000002
Q2 2020 10 91,041 RETA, NEM, ABX.TO, NVGS 13F-HR 8/14/2020 000104785920000003
Q1 2020 13 93,109 RETA, NEM, QQQ, SPY 13F-HR 5/15/2020 000104785920000002
Q4 2019 19 177,972 RETA, HUM, OXY, NEM 13F-HR 2/13/2020 000104785920000001
Q3 2019 21 129,601 RETA, NEM, HUM, ABBV 13F-HR 11/13/2019 000104785919000004
Q2 2019 25 129,831 RETA, HUM, OXY, NEM 13F-HR 8/14/2019 000104785919000003
Q1 2019 30 106,029 RETA, NVGS, NEM, PARR 13F-HR 5/14/2019 000104785919000002
Q4 2018 21 75,301 RETA, NVGS, JPM, AGN 13F-HR 2/13/2019 000104785919000001
Q3 2018 19 87,704 RETA, NVGS, IRIX, AGN 13F-HR 11/14/2018 000104785918000006
Q2 2018 23 76,950 NVGS, RETA, IRIX, AGN 13F-HR 8/14/2018 000104785918000004
Q1 2018 16 68,620 NVGS, IRIX, AGN, OXY 13F-HR 5/15/2018 000104785918000003
Q4 2017 20 120,212 SPY, C, NVGS, DAL 13F-HR 2/13/2018 000104785918000001
Q3 2017 23 117,112 NVGS, IRIX, SPY, C 13F-HR 11/13/2017 000104785917000004
Q2 2017 15 88,088 SPY, IRIX, PARR, NVGS 13F-HR 8/14/2017 000104785917000003
Q1 2017 20 93,022 NVGS, IRIX, PARR, MYL 13F-HR 5/15/2017 000104785917000002
Q4 2016 16 75,208 IRIX, NVGS, PARR, ESXB 13F-HR 2/13/2017 000104785917000001
Q3 2016 15 86,523 IRIX, PARR, BSFT, NVGS 13F-HR 11/14/2016 000104785916000019
Q2 2016 18 102,161 IRIX, AABA, PARR, NVGS 13F-HR 8/15/2016 000104785916000016
Q1 2016 17 119,270 CSCD, NVGS, PARR, IRIX 13F-HR 5/13/2016 000104785916000013
Q4 2015 18 117,020 PARR, CSCD, DAL, IRIX 13F-HR 2/16/2016 000104785916000011
Q3 2015 19 93,594 PARR, CSCD, DAL, NVGS 13F-HR 11/13/2015 000104785915000010
Q2 2015 23 115,626 MET, CSCD, NVGS, ISCA 13F-HR 8/13/2015 000104785915000005
Q1 2015 16 114,475 NVGS, CSCD, PARR, DAL 13F-HR 5/15/2015 000104785915000002
Q4 2014 19 157,783 AAL, C, BAC, CSCD 13F-HR 2/13/2015 000104785915000001
Q3 2014 17 134,718 C, AAL, BAC, HON 13F-HR 11/14/2014 000104785914000007
Q2 2014 20 125,321 AAL, GLD, HON, MET 13F-HR 8/13/2014 000104785914000005
Q1 2014 16 100,294 AAL, WPX, MET, UAL 13F-HR 5/13/2014 000104785914000004
Q4 2013 20 148,751 SPNC, UAL, MET, AAL 13F-HR 2/14/2014 000131586314000093